STOCK TITAN

Hims & Hers: Deborah M. Autor proposes $442K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) officer and director Deborah M. Autor reported a proposed sale of 23,828 Class A shares, with an approximate sale date of November 17, 2026 and an aggregate market value of $441,532.84. She acquired 23,828 shares through restricted stock vesting from the issuer on November 15, 2026. The notice lists May 20, 2026 as the plan adoption or instruction date under Rule 10b5-1. During the prior three months, she sold 16,773 Class A shares on August 18, 2026, for gross proceeds of $467,128.05.

Proposed sale 23,828 Class A shares Approximate sale date November 17, 2026
Aggregate market value $441,532.84 Proposed sale of 23,828 Class A shares
Shares acquired 23,828 shares Restricted stock vesting on November 15, 2026
Shares sold in prior three months 16,773 Class A shares Sale on August 18, 2026
Gross proceeds $467,128.05 Sale on August 18, 2026
Class A shares outstanding 226,034,799 shares Securities information
Restricted Stock Vesting technical
"Nature of Acquisition Transaction: Restricted Stock Vesting"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Rule 10b5-1 regulatory
"Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Aggregate Market Value financial
"Aggregate Market Value: 441532.84"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HIMS shares did Deborah M. Autor propose to sell?

Deborah M. Autor proposed to sell 23,828 Class A shares, with an approximate sale date of November 17, 2026 and an aggregate market value of $441,532.84. The shares were reported as acquired through restricted stock vesting on November 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading